Drs I.J.H. Vriens
-
Lammers, S. W. M., Geurts, S. M. E., Hermans, K. E. P. E., van Hellemond, I. E. G., Swinkels, A. C. P., Smorenburg, C. H., van der Sangen, M. J. C., Kroep, J. R., Honkoop, A. H., van den Berkmortel, F. W. P. J., de Roos, W. K., Imholz, A. L. T., Vriens, I. J. H., Tjan-Heijnen, V. C. G., & Dutch Breast Cancer Research Group (BOOG) for the DATA Investigators (2024). Ovarian function recovery in breast cancer patients receiving adjuvant anastrozole treatment: updated results from the phase 3 DATA trial. Breast Cancer Research and Treatment. Advance online publication. https://doi.org/10.1007/s10549-024-07411-wMore information about this publication
-
Lammers, S. W. M., Meegdes, M., Vriens, I. J. H., Voogd, A. C., de Munck, L., van Nijnatten, T. J. A., Keymeulen, K. B. M. I., Tjan-Heijnen, V. C. G., & Geurts, S. M. E. (2024). Treatment and survival of patients diagnosed with high-risk HR+/HER2- breast cancer in the Netherlands: a population-based retrospective cohort study. ESMO Open, 9(5), Article 103008. https://doi.org/10.1016/j.esmoop.2024.103008More information about this publication
-
Heimovaara, J. H., van Calsteren, K., Lok, C. A. R., Evens, A. M., Hoegl, J., Ferber, A., Fernandes, A., Vriens, I., van Zuylen, L., & Amant, F. (2024). Results of an international survey on the current organization of care for pregnant women with cancer. Acta Obstetricia et Gynecologica Scandinavica, 103(4), 751-756. https://doi.org/10.1111/aogs.14748More information about this publication
-
Welle-Butalid, M. E. T., van Osch, L., van Bree, B. E., Vriens, I. J. H., Derhaag, J. G., de Die-Smulders, C. E. M., Tjan-Heijnen, V. C. G., & van Golde, R. J. T. (2024). Considerations of breast cancer survivors to return for embryo transfer after fertility preservation: A qualitative study. European Journal of Obstetrics & Gynecology and Reproductive Biology, 293, 27-31. https://doi.org/10.1016/j.ejogrb.2023.12.009More information about this publication
-
Lammers, S. W. M., Thurisch, H., Vriens, I. J. H., Meegdes, M., Engelen, S. M. E., Erdkamp, F. L. G., Dercksen, M. W., Vriens, B. E. P. J., Aaldering, K. N. A., Pepels, M. J. A. E., van de Winkel, L. M. H., Peters, N. A. J. B., Tol, J., Heijns, J. B., van de Wouw, A. J., Teeuwen, N. J. A., Geurts, S. M. E., & Tjan-Heijnen, V. C. G. (2024). The prognostic impact of BMI in patients with HR+/HER2- advanced breast cancer: a study of the SONABRE registry. Breast Cancer Research and Treatment, 203(2), 339-349. https://doi.org/10.1007/s10549-023-07108-6More information about this publication
-
Lammers, S. W. M., Geurts, S. M. E., Van Hellemond, I. E. G., Swinkels, A. C. P., Smorenburg, C. H., Van Der Sangen, M. J. C., Kroep, J. R., De Graaf, H., Honkoop, A. H., Erdkamp, F. L. G., De Roos, W. K., Linn, S. C., Imholz, A. L. T., Smidt, M. L., Vriens, I. J. H., Tjan-Heijnen, V. C. G., & Dutch Breast Cancer Research Group (BOOG) for the DATA Investigators (2023). The prognostic and predictive effect of body mass index in hormone receptor-positive breast cancer. JNCI Cancer Spectrum, 7(6), Article pkad092. https://doi.org/10.1093/jncics/pkad092More information about this publication
-
Tjan-Heijnen, V. C. G., Lammers, S. W. M., Geurts, S. M. E., Vriens, I. J. H., Swinkels, A. C. P., Smorenburg, C. H., van der Sangen, M. J. C., Kroep, J. R., de Graaf, H., Honkoop, A. H., Erdkamp, F. L. G., de Roos, W. K., Linn, S. C., Imholz, A. L. T., & Dutch Breast Cancer Research Group (BOOG) for the DATA Investigators (2023). Extended adjuvant aromatase inhibition after sequential endocrine therapy in postmenopausal women with breast cancer: follow-up analysis of the randomised phase 3 DATA trial. EClinicalMedicine, 58(1), Article 101901. https://doi.org/10.1016/j.eclinm.2023.101901More information about this publication
-
Ibragimova, K. I. E., Geurts, S. M. E., Meegdes, M., Erdkamp, F., Heijns, J. B., Tol, J., Vriens, B. E. P. J., Dercksen, M. W., Aaldering, K. N. A., Pepels, M. J. A. E., van de Winkel, L., Peters, N. A. J. B., Teeuwen-Dedroog, N. J. A., Vriens, I. J. H., & Tjan-Heijnen, V. C. G. (2023). Outcomes for the first four lines of therapy in patients with HER2-positive advanced breast cancer: results from the SONABRE registry. Breast Cancer Research and Treatment, 198(2), 239-251. https://doi.org/10.1007/s10549-022-06832-9More information about this publication
-
Meegdes, M., Ibragimova, K. I. E., Lobbezoo, D. J. A., Vriens, I. J. H., Kooreman, L. F. S., Erdkamp, F. L. G., Dercksen, M. W., Vriens, B. E. P. J., Aaldering, K. N. A., Pepels, M. J. A. E., van de Winkel, L. M. H., Tol, J., Heijns, J. B., van de Wouw, A. J., Peters, N. A. J. B., Hochstenbach-Waelen, A., Smidt, M. L., Geurts, S. M. E., & Tjan-Heijnen, V. C. G. (2022). The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry. Breast Cancer Research and Treatment, 192(2), 331-342. https://doi.org/10.1007/s10549-021-06472-5More information about this publication
-
Ibragimova, K. I. E., Geurts, S. M. E., Croes, S., Erdkamp, F., Heijns, J. B., Tol, J., Vriens, B. E. P. J., Aaldering, K. N. A., Dercksen, M. W., Pepels, M. J. A. E., Peters, N. A. J. B., van de Winkel, L., Tilli, D. J. P., Vriens, I. J. H., de Boer, M., & Tjan-Heijnen, V. C. G. (2021). Survival before and after the introduction of pertuzumab and T-DM1 in HER2-positive advanced breast cancer, a study of the SONABRE Registry. Breast Cancer Research and Treatment, 188(2), 571-581. https://doi.org/10.1007/s10549-021-06178-8More information about this publication
![Placeholder](/sites/default/files/2024-05/Placeholder%20user.png)
Drs I.J.H. Vriens
Teacher
Interne Geneeskunde
School for Cardiovascular Diseases
Fac. Health, Medicine and Life Sciences